Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
NCT Number: NCT02200224
The purpose of this study is to:
1. determine the clinical impact of rapid Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) testing on antibiotic over and under treatment for CT/NG in women evaluated in the Emergency Department (ED) for a Sexually Transmitted Infection (STI). 2. determine the clinical impact of rapid Trichomonas Vaginalis (TV) testing on antibiotic under and over treatment for TV in women evaluated in the ED for an STI 3. evaluate the feasibility of integrating rapid Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) and TV testing in the Emergency Department setting.
To evaluate the impact or rapid CT/NG/TV testing an patient comprehension of Sexually Transmitted Infection diagnosis.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Baltimore, Maryland, 21287, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 week follow-up
Overtreatment is defined as CT/NG negative patients who received antibiotic treatment.
Johns Hopkins University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05405582
Communicable Diseases, Disease Attributes
Somkele, KwaZulu-Natal, South Africa
View Trial DetailsNCT05630859
Communicable Diseases, Disease Attributes
Washington D.C., District of Columbia, United States
View Trial DetailsNCT03709043
Alcohol Use Disorder, Alcohol-Related Disorders
San Francisco, California, United States
View Trial DetailsNCT01235091
Chemically-Induced Disorders, Communicable Diseases
View Trial Details